On March 10, 2023, Law360 published an article detailing AGG’s recent growth with Beth Moore joining as of counsel in the Atlanta office and of counsel John Dresch and associate Meicheng Zhu joining the Washington, D.C. office.
Beth joins the firm’s Entertainment & Sports industry team and Corporate & Finance practice. Regarding her time as a former Georgia legislator, Beth told Law360 she had the opportunity to see firsthand “how Georgia’s entertainment industry is breathing new life into conversations” about the state’s identity.
“Music, art, and entertainment have been the defining features of every culture throughout history, and now Georgia’s political leaders can see they’re also good for our economy and quality of life,” Beth said. “I have confidence that a broad majority of both Democrats and Republicans in the Georgia Legislature understand the importance of the entertainment industry to our state and will continue to support the policies that keep it here.”
John joins the firm’s Litigation and Intellectual Property practices, focusing his practice on patent preparation, prosecution, and appeals. He shared that his interest in tech and the law drove his interest in patent law began at a young age.
“Patent law has provided me the opportunity to combine my background in mechanical engineering, and passion for learning and understanding new technologies, with my equal passion for law,” John said. “I particularly enjoy providing personal attention to clients in navigating the patent process and assisting with developing, protecting, and managing their intellectual property assets to achieve their business objectives.”
John added that he is looking forward to joining “the growing intellectual property practice” in the firm’s Washington, D.C. office, where he would “be surrounded and supported by a collegial and cooperative group of attorneys” with a range of experience.
Meicheng joins the firm’s Litigation and Intellectual Property practices and brings a decade of pharmaceutical research experience in small molecule and ribonucleic acid drug technology to her law practice. She is also the co-inventor on 10 patents.
“That experience has helped shape my approach to helping clients protect their intellectual property rights with an understanding on the deeply complex innovations they are making in pharmaceuticals and other areas,” Meicheng said of her experience in new drug discovery and research.
To read the full article, please click here (subscription required).